Atherton Lane Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Atherton Lane Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$33.7M	Sell	490,259 -8,075	-2%	-$534K	1.96%	13
2015 Q3	$29.5M	Buy	498,334 +1,891	+0.4%	+$120K	1.84%	13
2015 Q2	$33M	Sell	496,443 -5,518	-1%	-$364K	1.83%	12
2015 Q1	$32.4M	Sell	501,961 -17,706	-3%	-$1.11M	1.75%	9
2014 Q4	$30.7M	Sell	519,667 -11,352	-2%	-$640K	1.68%	11
2014 Q3	$27.2M	Sell	531,019 -26,845	-5%	-$1.34M	1.55%	17
2014 Q2	$27.1M	Buy	557,864 +5,755	+1%	+$284K	1.5%	19
2014 Q1	$28.7M	Buy	552,109 +3,410	+0.6%	+$181K	1.77%	11
2013 Q4	$29.2M	Sell	548,699 -16,621	-3%	-$847K	1.84%	9
2013 Q3	$26.2M	Sell	565,320 -11,084	-2%	-$487K	1.79%	11
2013 Q2	$25.8M	Buy	+576,404	New	+$25M	1.88%	13

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Atherton Lane Advisers's BMY Position: Q4 2015 in Review

Atherton Lane Advisers reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q4 2015, selling an estimated $534K and leaving 490,259 shares worth $33.7M. The position accounts for 1.96% of the portfolio, ranked #13.

Atherton Lane Advisers first reported a position in BMY in Q2 2013 and has held it in 11 quarters since. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Atherton Lane Advisers held 490,259 shares of Bristol-Myers Squibb worth $33.7M as of Q4 2015.
Atherton Lane Advisers sold 8,075 Bristol-Myers Squibb shares in Q4 2015, an estimated $534K.
Bristol-Myers Squibb made up 1.96% of Atherton Lane Advisers's portfolio in Q4 2015, its #13 holding.
Atherton Lane Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 11 quarters since.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.